Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

Author: CormioLuigi, ElanderAnna, FagerlundAnders, LewinRichard, PalangiLina, Santanelli di PompeoFabio, SelvaggiGennaro

Paper Details 
Original Abstract of the Article :
INTRODUCTION: Gynecomastia and/or mastodynia is a common medical problem in patients receiving antiandrogen (bicalutamide or flutamide) treatment for prostate cancer; up to 70% of these patients result to be affected; furthermore, this can jeopardise patients' quality of life. AIMS: To systematical...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550398/

データ提供:米国国立医学図書館(NLM)

Managing Gynecomastia: A Side Effect of Prostate Cancer Treatment

Gynecomastia, or breast enlargement in men, is a common side effect of antiandrogen therapy used to treat prostate cancer. This research systematically reviewed the literature on treatment options for bicalutamide-induced gynecomastia, focusing on efficacy, safety, and patient quality of life. The review found that both tamoxifen and radiotherapy were effective in managing gynecomastia, with tamoxifen generally considered more effective than radiotherapy.

A Sensitive Issue: Managing Side Effects of Cancer Treatment

This research highlights the importance of managing side effects of cancer treatment, such as gynecomastia, to improve patient quality of life.

A Multidisciplinary Approach: Cancer Care and Support

This research emphasizes the importance of a multidisciplinary approach to cancer care, involving medical professionals from different specialties to address the various needs of patients.

Dr.Camel's Conclusion

This research is like a compass, guiding us through the complexities of managing gynecomastia, a common side effect of prostate cancer treatment.

Date :
  1. Date Completed 2016-05-24
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26308532

DOI: Digital Object Identifier

PMC4550398

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.